Navigation Links
New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations
Date:9/16/2009

RNA-based oligonucleotides. With a growing list of pharmaceutical partners and LNA rapidly becoming the chemistry-of-choice in RNA-targeted therapeutics, we are pleased to have Dr. Levin join our team to progress important new therapies into drug development."

Last month, Santaris Pharma A/S announced a multi-year worldwide strategic alliance with Shire plc to discover and develop new RNA-based medicines to treat rare genetic disorders utilizing Santaris Pharma's proprietary LNA Drug Platform. This collaboration adds to the growing list of mRNA and microRNA drug discovery and development partnerships, which includes Wyeth (delivery of lead candidates against up to ten targets), GlaxoSmithKline (four viral disease drug candidates) and Enzon Pharmaceuticals (eight cancer targets successfully delivered). Operations in the US aim to support existing relationships and generate new licensing and partnership opportunities.

About Locked Nucleic Acid (LNA) Drug Platform

The Locked Nucleic Acid (LNA) Drug Platform developed by Santaris Pharma A/S creates synthetic chemical versions of the normal nucleic acid building blocks of ribonucleic acids (RNA). These synthetic chemical versions called LNAs improve the drug-like qualities of resulting therapeutics (oligonucleotides) by boosting resistance to metabolism, increasing half-life and improving tissue uptake. LNA-based therapeutics demonstrate improved binding affinity to their target RNA, which increases potency many-fold over other nucleotide therapeutics. The greater potency of LNA in binding complementary RNA sequences also allows for the use of significantly shorter LNA oligonucleotide drugs which can be more effective than previous antisense or siRNA drugs.

About Santaris Pharma A/S

Santaris Pharma A/S is a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and micro
'/>"/>

SOURCE Santaris Pharma A/S
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
2. Californias International Stem Cell Collaborations Must Be Based on Scientific Merit, Consumer Group Says
3. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
4. Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009
5. Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production
6. Research breakthrough will lead to more accurate weather forecasts
7. OMT announces a breakthrough in the development of a novel human antibody platform
8. New drugs faster from natural compounds: A UC San Diego breakthrough
9. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
10. Light sensor breakthrough could enhance digital cameras
11. DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... (JBEI), one of three Department of Energy (DOE) bio-energy ... to protect its valuable intellectual property. , ... ... 15, 2009 -- Surety, LLC , the leading ... announced that the Joint BioEnergy Institute (JBEI), one of ...
(Date:12/15/2009)... Va., Dec. 15 AstraZeneca (NYSE: ... of Virginia (UVa) in Charlottesville, today announced ... research collaboration to enhance development of new ... with a secondary focus on peripheral vascular ... ) ,, The collaborative preclinical research projects ...
(Date:12/15/2009)... N.Y., Dec. 15 On January 20th, ... Society for Medical Publication Professionals (ISMPP) will be ... London, UK. More than 100 attendees are expected ... for publication professionals, editors, publishers, medical writers and ... medical publications and the impact of guidelines and ...
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), a molecular ... Ph.D. Chief Scientific Officer, Senior Vice President, ... be joining its board of directors upon ... "Bill brings more than 20 years research ... said Gail Page, Vermillion Executive Chairperson. ...
Breaking Biology Technology:Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4
... Md., May 28 GenVec, Inc. (Nasdaq: ... agreement with a single institutional investor for the sale of 9,615,385 ... of its common stock. The shares of common stock and ... common stock and a warrant to purchase one share of common ...
... Proteon also receives orphan drug designation for its lead ... Inc., announced today that it has completed a second ... additional $12 million and increasing the total equity capital ... equity investment came primarily from two new investors, Bessemer ...
... Chinese Academy of Sciences in Beijing, scientists have investigated ... understand how they may help in the development of ... The research focused on rotating magnetic fields, which play ... generators. The difficulty for technology at the atomic scale ...
Other Biology Technology:GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 3Proteon Therapeutics Completes Second Closing of Equity Financing; Raises Total Series B to $50 million 2
(Date:12/15/2009)... Spanish and American researchers found the fossil remains of a ... have published, for the first time, the results of the ... the young cetacean, possibly a baleen whale from the Mysticeti ... partial fossil remains of a whale from the Lower Pliocene ... but it is the first time that the results of ...
(Date:12/15/2009)... 15 The PTR Group, a leading real-time ... it has agreed to sponsor three high school teams ... Competition ( http://usfirst.org ). ,, The PTR ... in three different states. The teams from Atholton ... and James Madison HS in Vienna, VA all have ...
(Date:12/14/2009)... touching, or for Tasmanian devils biting each ... driven the dinosaurs to extinction through the transmission of ... f1000 Biology, highlights the ,paleobiological detective work, of David ... them to deduce that a protozoan parasite was to ... tyrannosaurid fossils. , The parasite,s modern-day equivalent, which infects ...
Breaking Biology News(10 mins):Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2Davis Vision United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 49665 1Davis Vision United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 49665 2Davis Vision United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 49665 3On HIV Testing Day HIVMA calls for health care reform to make testing routine every day 49660 1On HIV Testing Day HIVMA calls for health care reform to make testing routine every day 49660 2HIV Atlas Shows Virus Targeting Minorities 49655 1HIV Atlas Shows Virus Targeting Minorities 49655 2HIV Atlas Shows Virus Targeting Minorities 49655 3
... fluids is the standard emergency treatment in the ... UC San Diego bioengineering researchers have reported improved ... earlier studies in humans that have shown benefits ... than normal saline, the researchers combined hypertonic saline ...
... Hoenig and Aaron Welch, both graduate students at ... Marine UM Rosenstiel School students take home top ... Science, won first place in the High-Potential Venture ... Entrepreneurship Competition. The two Marine Affairs and ...
... bring together energy leaders, industry professionals and academicians representing ... North American Energy Summit (NAES) May 1-2 in the ... summit will feature experts with diverse backgrounds from the ... for future generations. , Distinguished guests include The ...
Other Biology News:Hyperviscous fluids: Better treatment for severe blood loss 2Hyperviscous fluids: Better treatment for severe blood loss 3Hyperviscous fluids: Better treatment for severe blood loss 4Aquaculture concept leaves judges 'goggle eyed' 2UTSA hosts North American Energy Summit May 1-2 2
... comes with a shutter (controlled via a TTL ... The DH-2000 Deuterium Tungsten Halogen Light ... tungsten halogen light sources in a single optical ... stable output from 215-200 nm. In addition, deep-UV ...
... Analysis Note: Agglutination activity is expressed in g ... in phosphate buffered saline, pH 6.8, of a ... activity is the lowest concentration to agglutinate a ... after 1 hour incubation at 25 C. ...
... Security ChemStation is a ... application for data acquisition, ... searching and reporting, addressing ... data security, integrity, and ...
... These handy dispensers save ... glasses, wipers, hats, and other ... benchtop storage bins for small ... and manufacturing. Clear acrylic. Open-slot ...
Biology Products: